| 000 | 01402 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513194054.0 | ||
| 264 | 0 | _c19991119 | |
| 008 | 199911s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/S0140-6736(99)03581-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilson, A M | |
| 245 | 0 | 0 |
_aDifferences in lung bioavailability between different propellants for fluticasone propionate. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cOct 1999 |
||
| 300 |
_a1357-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Letter; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAerosol Propellants |
| 650 | 0 | 4 |
_aAndrostadienes _xpharmacokinetics |
| 650 | 0 | 4 |
_aAnti-Asthmatic Agents _xpharmacokinetics |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aChlorofluorocarbons |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFluticasone |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHydrocarbons, Fluorinated |
| 650 | 0 | 4 |
_aHydrocortisone _xurine |
| 650 | 0 | 4 |
_aLung _xdrug effects |
| 650 | 0 | 4 | _aSingle-Blind Method |
| 700 | 1 | _aSims, E J | |
| 700 | 1 | _aOrr, L C | |
| 700 | 1 | _aLipworth, B J | |
| 773 | 0 |
_tLancet (London, England) _gvol. 354 _gno. 9187 _gp. 1357-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(99)03581-3 _zAvailable from publisher's website |
| 999 |
_c10490780 _d10490780 |
||